Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 20/20 | 0.48 |
| ▸ | RXRG | P48443 | 18/20 | 0.48 |
| ▸ | RXRB | P28702 | 17/20 | 0.48 |
| ▸ | RARG | P13631 | 7/20 | 0.46 |
| ▸ | RARB | P10826 | 7/20 | 0.46 |
| ▸ | RARA | P10276 | 5/20 | 0.46 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4970582 | 1.00 | RXRA (0.48) | RXRARXRGRXRBRARGRARB | |
| SCHEMBL6037039 | 0.81 | RXRA (0.49) | RXRARXRGRXRBRARGRARB | |
| SCHEMBL7920534 | 0.81 | RXRA (0.49) | RXRARXRGRXRBRARGRARB | |
| SCHEMBL6037050 | 0.80 | NOTUM (0.35) | RXRARXRGRXRBRARGRARB | |
| SCHEMBL6037048 | 0.80 | NOTUM (0.35) | RXRARXRGRXRBRARGRARB | |
| SCHEMBL8308616 | 0.79 | RXRA (0.48) | RXRARXRGRXRBRARGRARB | |
| SCHEMBL8308614 | 0.79 | RXRA (0.48) | RXRARXRGRXRBRARGRARB | |
| SCHEMBL8308391 | 0.70 | RXRA (0.51) | RXRARXRGRXRBRARGRARB | |
| SCHEMBL8308387 | 0.70 | RXRA (0.51) | RXRARXRGRXRBRARGRARB | |
| SCHEMBL8309065 | 0.70 | RXRA (0.51) | RXRARXRGRXRBRARGRARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1985297-A1 | CARBOXYLIC ACID COMPOUND AND USE THEREOF | Japan Tobacco, Inc. (JP) | 2008-10-29 | — | — | EP | claimed |
| US-20070197512-A1 | Carboxylic Acid Compounds and Use Thereof | JAPAN TOBACCO INC. (JP) | 2007-08-23 | — | — | US | claimed |
| EP-1985297-A1 | CARBOXYLIC ACID COMPOUND AND USE THEREOF | Japan Tobacco, Inc. (JP) | 2008-10-29 | — | — | EP | disclosed |
| US-20070197512-A1 | Carboxylic Acid Compounds and Use Thereof | JAPAN TOBACCO INC. (JP) | 2007-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070197512-A1 | Carboxylic Acid Compounds and Use Thereof | GLS, SLC10A1, SOAT1 | RXRA 2005/4885RXRG 2117/4885RXRB 2073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.